Ionis Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
Alternative companies in the scoring peer group for Ionis Pharmaceuticals Inc are displayedin the table. This dashboard includes a questions and answers section about Ionis Pharmaceuticals Inc. Full Sustainability assessment of Ionis Pharmaceuticals Inc can be reached by logging in.
Ionis Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.4; made up of an environmental score of 2.7, social score of 3.4 and governance score of 4.0.
3.4
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1186 | Simply Better Brands Corp | 3.5 | Medium |
| 1186 | Yunnan Baiyao Group Co Ltd | 3.5 | Medium |
| 1234 | Ionis Pharmaceuticals Inc | 3.4 | Medium |
| 1234 | Cassava Sciences Inc | 3.4 | Medium |
| 1234 | Brickell Biotech Inc | 3.4 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Ionis Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Ionis Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Ionis Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Ionis Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Ionis Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Ionis Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Ionis Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Ionis Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Ionis Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Ionis Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Ionis Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Ionis Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Ionis Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Ionis Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Ionis Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Ionis Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Ionis Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Ionis Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Ionis Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Ionis Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Ionis Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Ionis Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Ionis Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Ionis Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Ionis Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Ionis Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Ionis Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Ionis Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Ionis Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Ionis Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Ionis Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Ionis Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Ionis Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Ionis Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Ionis Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Ionis Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Ionis Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial partial lipodystrophy. It also develops medicines for various indications that are in phase 3 study, including Eplontersen as a monthly self-administered subcutaneous injection to treat all types of TTR amyloidosis; Olezarsen for patients with severe hypertriglyceridemia (SHTG); Donidalorsen for patients with hereditary angioedema; ION363 for patients with amyotrophic lateral sclerosis; Pelacarsen for patients with established cardiovascular disease and elevated lipoprotein(a); and Tofersen to inhibit the production of superoxide dismutase 1. In addition, the company develops medicines for metabolic diseases, infectious diseases, renal diseases, ophthalmic diseases, and cancer. It has a strategic collaboration with Biogen Inc.; and collaboration and license agreement with AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis AG, Roche, Janssen Biotech, Inc., and Flamingo Therapeutics, Inc. Ionis Pharmaceuticals, Inc. was founded in 1989 and is based in Carlsbad, California.